C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen-activated protein kinases

Abstract

Plasma C-reactive protein (CRP) concentration is increased in the metabolic syndrome, which consists of a cluster of cardiovascular disease risk factors, including insulin resistance. It is not known, however, whether CRP is merely a marker of accompanying inflammation or whether it contributes causally to insulin resistance. The objective of this study is to investigate the role that CRP may play in the development of insulin resistance. We examined the effect of single-dose intravenous administration of purified human (h)CRP on insulin sensitivity in Sprague-Dawley rats using the euglycemic, hyperinsulinemic clamp technique. hCRP was associated with impaired insulin suppression of endogenous glucose production with no reduction in peripheral tissue glucose uptake, suggesting that hCRP mediated insulin resistance in the liver but not extrahepatic tissues. We further assessed components of the insulin signaling pathway and mitogen-activated protein kinases (MAPKs) in the liver. Liver tissues derived from hCRP-treated rats showed reduced insulin-stimulated insulin receptor substrate (IRS) tyrosine phosphorylation, IRS/phosphatidylinositol 3-kinase (PI3K) association, and Akt phosphorylation, consistent with hCRP-induced impairment of hepatic insulin signaling. Furthermore, hCRP enhanced phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and p38 MAPK as well as IRS-1 Ser 612. Finally, we observed in primary cultured rat hepatocytes that U0126 (a selective inhibitor of MAPK/ERK kinase1/2) corrected hCRP-induced impairment of insulin signaling. Conclusions: hCRP plays an active role in inducing hepatic insulin resistance in the rat, at least in part by activating ERK1/2, with downstream impairment in the insulin signaling pathway. (HEPATOLOGY 2011;53:127-135)

Inflammatory markers and bariatric surgery: a meta-analysis

“…The relation between insulin resistance and CRP was found to be confounded by the body mass index, without an independent correlation in some human studies [89,90]. Recent in vitro studies and animal studies, however, have shown evidence to the contrary [91,92]. Some studies have reported that variation in CRP levels cannot be explained by BMI alone; this issue needs to be clarified [93].…”

Potential Impact of Quercetin and Idebenone against Immuno- inflammatory and Oxidative Renal Damage Induced in Rats by Titanium Dioxide Nanoparticles Toxicity

“…It was reported that up-regulation of CRP is closely associated with metabolic disturbances including, insulin resistance and related complications such as fatty liver disease and hyperglycemia 37 . It also has a principle role in the activation of proinflammatory pathways in various cell types 38,39 .…”

Metabolic effects of high‐dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction

“…Several proinflammatory cytokines, including interleukin-6 and tumor necrosis factor ␣, are known to interfere with the insulin receptor signaling cascade, resulting in impaired glucose uptake in insulin-sensitive tissues (29,30). The acute-phase protein CRP was similarly shown to induce insulin resistance by impairment of insulin signaling in an animal model (31). Importantly, proinflammatory cytokines have recently been shown to induce beta cell dysfunction (32).…”